FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068875560> ?p ?o ?g. }

• W2068875560 endingPage "638" @default.
• W2068875560 startingPage "638" @default.
• W2068875560 abstract "To compare 5 antihypertensive drugs and placebo for changes in quality of life (QL). To assess the relationship of lifestyle factors and change in lifestyle factors to QL in participants with stage I diastolic hypertension.The Treatment of Mild Hypertension Study (TOMHS) was a randomized, double-blind, placebo-controlled clinical trial with minimum participant follow-up of 4 years. It was conducted at 4 hypertension screening and treatment academic centers in the United States. The cohort consisted of 902 men and women with hypertension, aged 45 to 69 years, with diastolic blood pressures less than 100 mm Hg. Informed consent was obtained from each participant after the nature of the procedures had been fully explained. Sustained nutritional-hygienic intervention was administered to all participants to reduce weight, to reduce dietary sodium and alcohol intake, and to increase physical activity. Participants were randomized to take (1) acebutolol (n = 132); (2) amlodipine maleate (n = 131); (3) chlorthalidone (n = 126); (4) doxazosin mesylate (n = 134); (5) enalapril maleate (n = 135); or placebo (n = 234). Changes in 7 QL indexes were assessed based on a 35-item questionnaire: (1) general health; (2) energy or fatigue; (3) mental health; (4) general functioning; (5) satisfaction with physical abilities; (6) social functioning; and (7) social contacts.At baseline, higher QL was associated with older age, more physical activity, lower obesity level, male gender, non-African American race, and higher educational level. Improvements in QL were observed in all randomized groups, including the placebo group during follow-up; greater improvements were observed in the acebutolol and chlorthalidone groups and were evident throughout follow-up. The amount of weight loss, increase in physical activity, and level of attained blood pressure control during follow-up were related to greater improvements in QL.In patients with stage I hypertension, antihypertensive treatment with any of 5 agents used in TOMHS does not impair QL. The diuretic chlorthali-done and the cardioselective beta-blocker acebutolol appear to improve QL the most. Success with lifestyle changes affecting weight loss and increase in physical activity relate to greater improvements in QL and show that these interventions, in addition to contributing to blood pressure control, have positive effects on the general well-being of the individual." @default.
• W2068875560 created "2016-06-24" @default.
• W2068875560 creator A5014577024 @default.
• W2068875560 creator A5015479789 @default.
• W2068875560 creator A5015724516 @default.
• W2068875560 creator A5042964774 @default.
• W2068875560 creator A5069472381 @default.
• W2068875560 creator A5073505205 @default.
• W2068875560 creator A5078856438 @default.
• W2068875560 creator A5087659816 @default.
• W2068875560 date "1997-03-24" @default.
• W2068875560 modified "2023-09-27" @default.
• W2068875560 title "Relationships of Quality-of-Life Measures to Long-term Lifestyle and Drug Treatment in the Treatment of Mild Hypertension Study" @default.
• W2068875560 cites W113241274 @default.
• W2068875560 cites W131312673 @default.
• W2068875560 cites W147138673 @default.
• W2068875560 cites W1963949168 @default.
• W2068875560 cites W1984527304 @default.
• W2068875560 cites W2022686869 @default.
• W2068875560 cites W2044036453 @default.
• W2068875560 cites W2046694319 @default.
• W2068875560 cites W2087900904 @default.
• W2068875560 cites W2090781981 @default.
• W2068875560 cites W2116212532 @default.
• W2068875560 cites W2122256402 @default.
• W2068875560 cites W2133396419 @default.
• W2068875560 cites W2138839431 @default.
• W2068875560 cites W2139480984 @default.
• W2068875560 cites W2148080108 @default.
• W2068875560 cites W228126680 @default.
• W2068875560 cites W2319337721 @default.
• W2068875560 cites W2332694193 @default.
• W2068875560 cites W2403908502 @default.
• W2068875560 cites W2423319722 @default.
• W2068875560 cites W3036753114 @default.
• W2068875560 cites W57181363 @default.
• W2068875560 cites W2145160336 @default.
• W2068875560 doi "https://doi.org/10.1001/archinte.1997.00440270080007" @default.
• W2068875560 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9080918" @default.
• W2068875560 hasPublicationYear "1997" @default.
• W2068875560 type Work @default.
• W2068875560 sameAs 2068875560 @default.
• W2068875560 citedByCount "172" @default.
• W2068875560 countsByYear W20688755602012 @default.
• W2068875560 countsByYear W20688755602013 @default.
• W2068875560 countsByYear W20688755602014 @default.
• W2068875560 countsByYear W20688755602015 @default.
• W2068875560 countsByYear W20688755602016 @default.
• W2068875560 countsByYear W20688755602017 @default.
• W2068875560 countsByYear W20688755602018 @default.
• W2068875560 countsByYear W20688755602019 @default.
• W2068875560 countsByYear W20688755602020 @default.
• W2068875560 countsByYear W20688755602021 @default.
• W2068875560 countsByYear W20688755602022 @default.
• W2068875560 crossrefType "journal-article" @default.
• W2068875560 hasAuthorship W2068875560A5014577024 @default.
• W2068875560 hasAuthorship W2068875560A5015479789 @default.
• W2068875560 hasAuthorship W2068875560A5015724516 @default.
• W2068875560 hasAuthorship W2068875560A5042964774 @default.
• W2068875560 hasAuthorship W2068875560A5069472381 @default.
• W2068875560 hasAuthorship W2068875560A5073505205 @default.
• W2068875560 hasAuthorship W2068875560A5078856438 @default.
• W2068875560 hasAuthorship W2068875560A5087659816 @default.
• W2068875560 hasConcept C126322002 @default.
• W2068875560 hasConcept C142724271 @default.
• W2068875560 hasConcept C159110408 @default.
• W2068875560 hasConcept C168563851 @default.
• W2068875560 hasConcept C1862650 @default.
• W2068875560 hasConcept C204787440 @default.
• W2068875560 hasConcept C27081682 @default.
• W2068875560 hasConcept C2778679995 @default.
• W2068875560 hasConcept C2779951463 @default.
• W2068875560 hasConcept C2780427769 @default.
• W2068875560 hasConcept C71924100 @default.
• W2068875560 hasConcept C72563966 @default.
• W2068875560 hasConcept C84393581 @default.
• W2068875560 hasConceptScore W2068875560C126322002 @default.
• W2068875560 hasConceptScore W2068875560C142724271 @default.
• W2068875560 hasConceptScore W2068875560C159110408 @default.
• W2068875560 hasConceptScore W2068875560C168563851 @default.
• W2068875560 hasConceptScore W2068875560C1862650 @default.
• W2068875560 hasConceptScore W2068875560C204787440 @default.
• W2068875560 hasConceptScore W2068875560C27081682 @default.
• W2068875560 hasConceptScore W2068875560C2778679995 @default.
• W2068875560 hasConceptScore W2068875560C2779951463 @default.
• W2068875560 hasConceptScore W2068875560C2780427769 @default.
• W2068875560 hasConceptScore W2068875560C71924100 @default.
• W2068875560 hasConceptScore W2068875560C72563966 @default.
• W2068875560 hasConceptScore W2068875560C84393581 @default.
• W2068875560 hasIssue "6" @default.
• W2068875560 hasLocation W20688755601 @default.
• W2068875560 hasLocation W20688755602 @default.
• W2068875560 hasOpenAccess W2068875560 @default.
• W2068875560 hasPrimaryLocation W20688755601 @default.
• W2068875560 hasRelatedWork W107895376 @default.
• W2068875560 hasRelatedWork W2021488331 @default.
• W2068875560 hasRelatedWork W2090807455 @default.
• W2068875560 hasRelatedWork W2154556361 @default.

• next